A novel synthetic adjuvant enhances dendritic cell function

Immunology

Volumn 128, Issue 1 PART 2, 2009, Pages

  Phillipps, Karen S M ^a   Wykes, Michelle N ^b   Liu, Xue Q ^b   Brown, Melissa ^a   Blanchfield, Joanne ^a   Toth, Istvan ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Adjuvant; Dendritic cells; LCP system; Toll like receptor 2; Vaccine delivery

Indexed keywords

IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; LIPID CORE PEPTIDE; OVALBUMIN; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOREACTIVITY; MIXED LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DENDRITIC CELLS; FEMALE; HUMANS; INTERLEUKIN-12; MICE; MICE, INBRED C57BL; OVALBUMIN; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2; TRANSFECTION; UP-REGULATION; VACCINES;

EID: 68249133732     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.03038.x     Document Type: Article

References (38)

1. Moyle PM, Olive C, Ho MF, Good MF, Toth I. Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A streptococcal vaccine, and subsequent immunological evaluation. J Med Chem 2006 49 : 6364 79.
2. Olive C, Batzloff MR, Horvath A, Clair T, Yarwood P, Toth I, Good MF. Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct. Indian J Med Res 2004 119 (Suppl. 88 94.
3. Olive C, Batzoff MR, Horvath A, Wong A, Clair T, Yarwood P, Toth I, Good M. A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologus opsonic antibodies. Infect Immun 2002 70 : 2734 8.
4. Zhong G, Toth I, Reid R, Bruhman RC. Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis. J Immunol 1993 151 : 3728 36.
5. McLellan A, Kapp M, Eggert AA, Linden C, Bommhardt U, Brocker E-V, Kammerer U, Kampgen E. Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression. Blood 2002 99 : 2084 92.
6. Vremec D, Pooley J, Hochrein H, Wu L, Shortman K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J Immunol 2000 164 : 2978 86.
7. Takeda K, Kaisho T, Akira S. Toll like receptors. Annu Rev Immunol 2003 21 : 335 76.
8. Edwards AD, Diebold SS, Slack EM, Tomizawa H, Hemmi H, Kaisho T, Akira S, Reis e Sousa C. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol 2003 33 : 827 33.
9. Boonstra A, Asselin-Paturel C, Gilliet M, Crain C, Trinchieri G, Liu YJ, O'Garra A. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J Exp Med 2003 197 : 101 9.
10. Boonstra A, Rajsbaum R, Holman M et al. Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J Immunol 2006 177 : 7551 8.
11. Sandor F, Buc M. Toll-like receptors I. Structure, function and their ligands. Folia Biol 2005 51 : 148 56.
12. Takeda K, Takeuchi O, Akira S. Recognition of lipopeptides by Toll-like receptors. J Endotoxin Res 2002 8 : 459 63.
13. Akira S, Takeda K. Toll-like receptor signaling. Nat Rev Immunol 2004 4 : 499 511.
14. Hajjar AM, O'Mahony DS, Ozinsky A, Underhill DM, Aderem A, Klebanoff SJ, Wilson CB. Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J Immunol 2001 166 : 15 9.
15. Wyllie DH, Kiss-Toth E, Visintin A, Smith SC, Boussouf S. Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses. J Immunol 2000 165 : 7125 32.
16. Takeuchi O, Horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, Akira S. Role of TLR1 in mediating immune response to microbial lipoproteins. J Immunol 2002 169 : 10 4.
17. Lien E, Sellati TJ, Toshimura A et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999 274 : 33419 24.
18. Into T, Kiura K, Yasuda M et al. Stimulation of human Toll-like receptor (TLR) 2 and TLR6 with membrane lipoproteins of Mycoplasma fermentans induces apoptotic cell death after NF-kappa B activation. Cell Microbiol 2004 6 : 187 99.
19. Nakao Y, Funami K, Satomi K, Taniguchi M, Nishiguchi M, Fukumori Y, Seya T, Matsumoto M. Surface-expressed TLR6 participates in the recognition of diacylated lipopeptide and peptidoglycan in human cells. J Immunol 2005 175 : 1566 73.
20. Buwitt-Beckman U, Heine H, Wiesmuller KH, Jung G, Brock R, Akira S, Ulmer AJ. Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur J Immunol 2005 35 : 282 9.
21. Buwitt-Beckman U, Heine H, Wiesmuller KH, Jung G, Brock R, Akira S, Ulmer AJ. TLR1- and TLR6-independent recognition of bacterial lipopeptides. J Biochem 2006 281 : 9049 57.
22. MacPherson GG, Wykes M, Huang FP, Jenkins CD. Isolation of dendritic cells from rat intestinal lymph and spleen. In : Robinson SP, Stagg AJ, eds. Dendritic Cells Protocols, Vol. 1. London, UK : Humana Press, 2001 : 29 41.
23. Wykes M, Pombo A, Jenkins C, MacPherson GG. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J Immunol 1998 161 : 1313 9.
24. Yi AK, Chang M, Peckham DW, Krieg AM, Ashman RF. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol 1998 160 : 5898 906.
25. Bhatia S, Edidin M, Almo SC, Nathenson SG. B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties. Immunol Lett 2006 104 : 70 5.
26. Boscardin SB, Hafalla JCR, Masilamani RF et al. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J Exp Med 2006 203 : 599 606.
27. Macatonia SE, Hosken NA, Litton M et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 1995 154 : 5071 9.
28. Badiee A, Davies N, McDonald K, Radford K, Michiue H, Hart D, Kato M. Enhanced delivery of immunoliposomes to human dendritic cells by targeting the multilectin receptor DEC-205. Vaccine 2007 25 : 4757 66.
29. Mahnke K, Guo M, Lee S, Sepulveda H, Swain SL, Nussenzweig M, Steinman RM. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol 2000 151 : 673 84.
30. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007 7 : 19 30.
31. Villadangos JA, Young L. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 2008 29 : 352 61.
32. Jackson DC, Lau YF, Le T et al. A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses. Proc Natl Acad Sci USA 2004 101 : 15440 5.
33. Dearman RJ, Cumberbatch M, Maxwell G, Basketter A, Kimber I. Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells. Immunology 2008 Epub ahead of print.
34. Lombardi V, Overtvelt vL, Horiot S et al. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route. Clin Exp Allergy 2008 38 : 1819 29.
35. Patel M, Xu D, Kewin P, Choo-Kang B, McSharry C, Thomson NC, Liew FY. TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells1. J Immunol 2005 174 : 7558 63.
36. Dillon S, Agrawal S, Van Dyke T et al. A TLR2 ligand stimulates Th2 responses in vivo, via induction of ERK MAP kinase and c-Fos in dendritic cells. J Immunol 2004 172 : 4733 4743.
37. Reverts H, Pynaert G, Grooten J, de Baetselier P. Lipoprotein I, a TLR2/4 ligand modulates Th2-deriven allergic immune responses. J Immunol 2005 174 : 1097 103.
38. Doxsee CL, Riter TR, Reiter MJ, Gibson SJ, Vasilakos JP, Kedl RM. The immune response modifier and Toll-like receptor 7 agonist S-27609 selectively induces IL-12 and TNF-alpha production in CD11c+CD11b+CD8- dendritic cells. J Immunol 2003 171 : 1156 63.